Skip to main content
. 2019 Mar 16;20(6):1328. doi: 10.3390/ijms20061328

Figure 2.

Figure 2

Arctigenin inhibits the arecoline-induced collagen contraction and migration capacities of BMF. (A) Arecoline-treated BMFs with or without arctigenin were subjected to collagen gel contraction assay (three replicates for each concentration). The gel areas (dotted circles) were calculated using ImageJ software. Representative images are presented; (B) Cell migration was measured 48 hours post-arctigenin exposure in arecoline-stimulated BMFs. * p < 0.05 as compared with the non-arctigenin-treated group; # p < 0.05 as compared with the arecoline group. Magnification, ×100.